Search research articles
Contact Us
Filters
Showing results (191-200 of 334) with videos related to
Page
of 34
Sort By:
Cancer Research
|
June 23, 2023
Whole Slide Imaging-Based Prediction of TP53 Mutations Identifies an Aggressive Disease Phenotype in Prostate Cancer
Marija Pizurica, Maarten Larmuseau, Kim Van der Eecken, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 28, 2019
Radiation Dosimetry and Biodistribution of <sup>18</sup>F-PSMA-11 for PET Imaging of Prostate Cancer
Sarah Piron, Kathia De Man, Nick Van Laeken, et al.
European Urology Open Science
|
August 2, 2021
The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-volume Metastatic Prostate Cancer. Results from the Local Treatment of Metastatic Prostate Cancer (LoMP) Registry
Nicolaas Lumen, Elise De Bleser, Sarah Buelens, et al.
European Urology Focus
|
July 21, 2017
Practice Patterns Compared with Evidence-based Strategies for the Management of Androgen Deprivation Therapy-Induced Side Effects in Prostate Cancer Patients: Results of a European Web-based Survey
Renée Bultijnck, Cristian Surcel, Guillaume Ploussard, et al.
Cancers
|
April 3, 2021
Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resistant Prostate Cancer
Bram De Laere, Alessio Crippa, Ashkan Mortezavi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 19, 2015
Biological 18[F]-FDG-PET image-guided dose painting by numbers for painful uncomplicated bone metastases: A 3-arm randomized phase II trial
Dieter Berwouts, Katrien De Wolf, Bieke Lambert, et al.
European Urology
|
November 5, 2018
Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer: A Systematic Review
Guillaume Ploussard, Giorgio Gandaglia, Hendrik Borgmann, et al.
Journal of Translational Medicine
|
July 1, 2017
A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response
Nora Sundahl, Katrien De Wolf, Sylvie Rottey, et al.
European Urology
|
July 21, 2015
Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis
Piet Ost, Barbara Alicja Jereczek-Fossa, Nicholas Van As, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 9, 2022
Health related quality of life outcomes following stereotactic body radiotherapy in patients with oligo-metastatic disease: A systematic review and individual patient data meta-analysis
Aisling S Barry, Joelle Helou, Andrea Bezjak, et al.
Page
of 34
Search research articles
Search
Showing results (191-200 of 334) with videos related to
Sort By:
Page
of 34
Cancer Research
|
June 23, 2023
Whole Slide Imaging-Based Prediction of TP53 Mutations Identifies an Aggressive Disease Phenotype in Prostate Cancer
Marija Pizurica, Maarten Larmuseau, Kim Van der Eecken, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 28, 2019
Radiation Dosimetry and Biodistribution of <sup>18</sup>F-PSMA-11 for PET Imaging of Prostate Cancer
Sarah Piron, Kathia De Man, Nick Van Laeken, et al.
European Urology Open Science
|
August 2, 2021
The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-volume Metastatic Prostate Cancer. Results from the Local Treatment of Metastatic Prostate Cancer (LoMP) Registry
Nicolaas Lumen, Elise De Bleser, Sarah Buelens, et al.
European Urology Focus
|
July 21, 2017
Practice Patterns Compared with Evidence-based Strategies for the Management of Androgen Deprivation Therapy-Induced Side Effects in Prostate Cancer Patients: Results of a European Web-based Survey
Renée Bultijnck, Cristian Surcel, Guillaume Ploussard, et al.
Cancers
|
April 3, 2021
Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resistant Prostate Cancer
Bram De Laere, Alessio Crippa, Ashkan Mortezavi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 19, 2015
Biological 18[F]-FDG-PET image-guided dose painting by numbers for painful uncomplicated bone metastases: A 3-arm randomized phase II trial
Dieter Berwouts, Katrien De Wolf, Bieke Lambert, et al.
European Urology
|
November 5, 2018
Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer: A Systematic Review
Guillaume Ploussard, Giorgio Gandaglia, Hendrik Borgmann, et al.
Journal of Translational Medicine
|
July 1, 2017
A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response
Nora Sundahl, Katrien De Wolf, Sylvie Rottey, et al.
European Urology
|
July 21, 2015
Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis
Piet Ost, Barbara Alicja Jereczek-Fossa, Nicholas Van As, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 9, 2022
Health related quality of life outcomes following stereotactic body radiotherapy in patients with oligo-metastatic disease: A systematic review and individual patient data meta-analysis
Aisling S Barry, Joelle Helou, Andrea Bezjak, et al.
Page
of 34